Diabetes Prevention Program attendance is associated with improved patient activation: Results from the Prediabetes Informed Decisions and Education (PRIDE) study

Abstract

The Diabetes Prevention Program (DPP) is a 12-month behavior change program designed to increase physical activity and improve dietary patterns among patients at risk for Type 2 diabetes, in order to facilitate modest weight loss and improve cardio-metabolic profiles. It is unknown whether baseline patient activation is related to increased DPP uptake, and whether DPP attendance leads to subsequent improvement in patient activation. We analyzed data from 352 adult participants in the Prediabetes Informed Decisions and Education (PRIDE) trial of shared decision-making (SDM) in diabetes prevention, collected from November 2015 through September 2017. PRIDE participants completed baseline and 4-month follow-up surveys, including the Altarum Consumer Engagement (ACE) Measure™ of patient activation. We tracked DPP attendance over 8 months using data from partnering DPP providers. In multivariate models, we measured whether self-reported baseline activation was associated with DPP “uptake” (1+ session attended) or DPP “attendance” (9+ sessions). We also examined whether DPP attendance was associated with change in activation at 4-months follow-up. We did not find an association between baseline activation and DPP uptake or attendance. However, we did find that DPP attendance was associated with an increase in the overall ACE score (6.68 points, 95% CI 1.97–11.39, p = 0.005) and increased activation in 2 of the 3 ACE subscales (Commitment and Informed Choice). Our finding of increased patient activation with DPP attendance suggests a mechanism for the improved health outcomes seen in DPP real-world translational studies. This work has important implications for diabetes prevention and other behavior change programs.

Relationship between Citizens’ Health Engagement and Intention to Take the COVID-19 Vaccine in Italy: A Mediation Analysis

“…Moreover, we demonstrated the predictive role of the individual's general health engagement attitude in the intention to vaccinate against COVID-19. Our results corroborate the relevance of studying the general individual's psychological attitude towards their health promotion and self-management-namely, health engagement-as a relevant factor impacting on preventive behaviors [15,[32][33][34]. Furthermore, these data corroborate the value of extending the current debate about patient engagement to the specific scope of vaccine intention [35].…”

Change in Weight, BMI, and Body Composition in a Population‐Based Intervention Versus Genetic‐Based Intervention: The NOW Trial

“…Given that participants who were enrolled in the GLB program were invited to participate in the study, this appears to be a representative sample of individuals interested in this weight‐management program. Furthermore, the NOW trial study population is similar to other reported GLB study populations (40‐43).…”

Weight Loss Disparities Among Hispanic and Underserved Participants, Colorado, 2015–2018

“…Translation of this program to real-world settings and delivery to medically underserved populations and those at increased risk, however, may yield less effective outcomes. In alignment with previous studies ( 14 , 17 , 28 ), our findings highlight that program attendance and engaging in the recommended amounts of physical activity are key drivers of program effectiveness. Not all participants, however, are able to meet attendance and physical activity recommendations.…”